Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

TLA Targeted Immuno Therapies AB

Closing information (x1000 EUR)

Closing information 2021/12 2020/12 2019/12
Turnover 178 More Arrow 1,591 More Arrow 1,841
Financial expenses 66 Less Arrow 39 Less Arrow 9
Earnings before taxes -620 More Arrow -58 More Arrow 0
EBITDA -479 More Arrow 2 Less Arrow -35
Total assets 2,901 Less Arrow 2,491 Less Arrow 1,589
Current assets 651 More Arrow 913 More Arrow 1,526
Current liabilities 1,602 Less Arrow 590 More Arrow 1,566
Equity capital -214 More Arrow 414 Less Arrow 23
- share capital 26 Equal arrow 26 Less Arrow 25
Employees (average) 4 More Arrow 6 More Arrow 7

Financial ratios

Fiscal year 2021/12 2020/12 2019/12
Solvency -7.4% More Arrow 16.6% Less Arrow 1.4%
Turnover per employee 44 More Arrow 265 Less Arrow 263
Profit as a percentage of turnover -348.3% More Arrow -3.6% More Arrow 0%
Return on assets (ROA) -19.1% More Arrow -0.8% More Arrow 0.6%
Current ratio 40.6% More Arrow 154.7% Less Arrow 97.4%
Return on equity (ROE) 289.7% Less Arrow -14.0% More Arrow 0%
Change turnover -1,384 More Arrow -322 More Arrow 225
Change turnover % -89% More Arrow -17% More Arrow 14%
Chg. No. of employees -2 More Arrow -1 More Arrow 2
Chg. No. of employees % -33% More Arrow -14% More Arrow 40%

Total value of public sale

Fiscal year 2021/12 2020/12 2019/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.